Hospital Clínic de Barcelona

Hospital


Location: Barcelona, Spain (ES) ES

ISNI: 0000000096359413

ROR: https://ror.org/02a2kzf50

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The impact of histopathology on prognosis of squamous cell carcinoma of the larynx: can we do better? (2025) Zidar N, Thompson LD, Agaimy A, Stenman G, Hellquist H, Nadal A, Mäkitie AA, et al. Journal article, Review article Depressive Symptoms and Amyloid Pathology (2025) Wiels WA, Oomens JE, Engelborghs S, Baeken C, Von Arnim CA, Boada M, Didic M, et al. Journal article The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study (2025) Rangelova E, Stoop TF, van Ramshorst TM, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, et al. Journal article Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study (2024) Neven P, Stahl N, Vidal M, Martín M, Kaufman PA, Harbeck N, Hunt KK, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum Five-year results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement-The ARISE Study and ARISE Registry Data (2024) Horke A, Tudorache I, Laufer G, Andreas M, Pomar JL, Pereda D, Quintana E, et al. Journal article Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell–mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods (2024) Drachenberg CB, Büttner-Herold M, Aguiar PV, Horsfield C, Mikhailov AV, Papadimitriou JC, Seshan SV, et al. Journal article